A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis

Cynthia S. Palmer, Bess Miller, Michael T. Halpern, Lawrence J. Geiter

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

A hypothetical cohort of 25,000 TB patients and their contacts were followed for a 10-year period; rates of treatment default, infectiousness following partial treatment, relapse, hospitalization, and development of drug-resistant TB were included. The average cost per case cured was $16,846 with 15% of patients starting DOT, $17,323 with 100% starting DOT, and $20,106 with none starting DOT. The incremental cost per additional case cured was $24,064 when all patients, started treatment on DOT, indicating that outpatient DOT provides a cost-effective method of improving health outcomes for TB patients and their contacts while controlling direct costs.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalJournal of Public Health Management and Practice
Volume4
Issue number3
DOIs
StatePublished - May 1998

Keywords

  • Cost effectiveness
  • Costs
  • Decision model
  • Health economics
  • Public health
  • Tuberculosis

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis'. Together they form a unique fingerprint.

  • Cite this